Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Rhein Biotech licenses RC-529 for use in hepatitis B vaccines

April 11, 2002

Sankyo presents new immunosuppressants in recent patent

April 10, 2002

Berna Biotech and Iomai collaborate to develop transdermal patch vaccines

April 10, 2002

Phase I trial initiated for Cytovaxine in the prevention of P. aeruginosa infections

April 8, 2002

FluINsure influenza vaccine meets immune response endpoints in phase I trial

April 4, 2002

TA-HPV gives promising phase II results in HPV-positive AGIN

April 3, 2002

Ono scientists present new CB2 receptor agonists

March 27, 2002

Sequella Global Tuberculosis Foundation collaborates to develop new TB vaccines

March 27, 2002

Encouraging phase I results reported for StreptAvax vaccine

March 25, 2002

Isotechnika enters negotiations for drug development agreement

March 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...